Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kjeld Schmiegelow & Marianne Ifversen. (1996) Myelotoxicity, Pharmacokinetics, and Relapse Rate with Methotrexate/6-Mercaptopurine Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology 13:5, pages 433-441.
Read now
Read now
Kenneth Lucas, Mary Jean Gula & Julie Blatt. (1992) Relapse in Acute Lymphoblastic Leukemia as a Function of White Blood Cell and Absolute Neutrophil Counts During Maintenance Chemotherapy. Pediatric Hematology and Oncology 9:2, pages 91-97.
Read now
Read now
Salah Hayder, Olle Björk & Bo Nilsson. (1992) Relapse Factors During Maintenance Therapy of Acute Lymphoblastic Leukemia in Children. Pediatric Hematology and Oncology 9:1, pages 21-27.
Read now
Read now
Jan Liliemark, Birgitta Pettersson, MÅRten Järnmark & Curt Peterson. (1991) On the Cellular Pharmacokinetics of 6-Thioguanine in Acute Myelogenous Leukemia. Leukemia & Lymphoma 4:4, pages 271-276.
Read now
Read now
Kjeld Schmiegelow. (1991) Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology 8:4, pages 301-312.
Read now
Read now
J. S. Lilleyman. (1991) Variables and Paradoxes in “Maintenance” Therapy of Lymphoblastic Leukemia. Pediatric Hematology and Oncology 8:4, pages ix-xii.
Read now
Read now
Articles from other publishers (15)
Guillermo Gervasini, Silvia G. de Murillo, Mercedes Jiménez, María D. de la Maya & Jose M. Vagace. (2017) Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy. Journal of Pediatric Hematology/Oncology 39:8, pages 589-595.
Crossref
Crossref
Kjeld Schmiegelow, Jacob Nersting, Stine Nygaard Nielsen, Mats Heyman, Finn Wesenberg, Jon Kristinsson, Kim Vettenranta, Henrik Schrøeder, Richard Weinshilboum, Katrine Lykke Jensen, Kathrine Grell & Susanne Rosthoej. (2016) Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?. Pediatric Blood & Cancer 63:12, pages 2104-2111.
Crossref
Crossref
Stine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, Thomas Leth Frandsen, Lisa Lyngsie Hjalgrim & Kjeld Schmiegelow. (2016) Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology 78:5, pages 983-994.
Crossref
Crossref
Kjeld Schmiegelow, Stine N. Nielsen, Thomas L. Frandsen & Jacob Nersting. (2014) Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 36:7, pages 503-517.
Crossref
Crossref
Anne McTiernan, Rachel C. Jinks, Matthew R. Sydes, Barbara Uscinska, Jane M. Hook, Martine van Glabbeke, Vivien Bramwell, Ian J. Lewis, Antonie H.M. Taminiau, Marianne A. Nooij, Pancras C.W. Hogendoorn, Hans Gelderblom & Jeremy S. Whelan. (2012) Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup. European Journal of Cancer 48:5, pages 703-712.
Crossref
Crossref
Mette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, Arja Harila‐Saari, Olafur G. Jonsson, Jukka Kanerva, Anna Lindblom, Bendik Lund, Elisabeth W. Andersen & Kjeld Schmiegelow. (2011)
Pneumocystis jiroveci
pneumonia prophylaxis during maintenance therapy influences methotrexate/6‐mercaptopurine dosing but not event‐free survival for childhood acute lymphoblastic leukemia
. European Journal of Haematology 88:1, pages 78-86.
Crossref
Crossref
Andr? Baruchel. (2007) Adolescents and young adults with acute lymphoblastic leukaemia: A new frontier?. European Journal of Cancer Supplements 5:5, pages 203-208.
Crossref
Crossref
Vaskar Saha & Judith Chessells. 2007. Evidence‐based Pediatric Oncology. Evidence‐based Pediatric Oncology
250
278
.
Jonathan Bury, Chris Hurt, Anindita Roy, Louise Cheesman, Mike Bradburn, Simon Cross, John Fox & Vaskar Saha. (2005) LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia. British Journal of Haematology 129:6, pages 746-754.
Crossref
Crossref
Kjeld Schmiegelow, Henrik Schr�der & Marianne Schmiegelow. (1994) Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?. Cancer Chemotherapy and Pharmacology 34:3, pages 209-215.
Crossref
Crossref
G. E. Janka, O. Gobrecht & S. Gross. 1994. Acute Leukemias IV. Acute Leukemias IV
338
343
.
Kjeld Schmiegelow & Ivan Bruunshuus. (1990) 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia. Cancer Chemotherapy and Pharmacology 26:4, pages 288-292.
Crossref
Crossref
Kjeld Schmiegelow & Malgorzata K. Pulczynska. (2009) White-cell counts in childhood acute lymphoblastic leukemia. European Journal of Haematology 44:1, pages 72-74.
Crossref
Crossref
G Dolan, J S Lilleyman & S M Richards. (1989) Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.. Archives of Disease in Childhood 64:9, pages 1231-1234.
Crossref
Crossref
Kjeld Schmiegelow, Henrick Schr�der, Malgorzata K. Pulczynska & Mogens Hejl. (1989) Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes. Cancer Chemotherapy and Pharmacology 25:1, pages 65-69.
Crossref
Crossref